Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH for Recurrent IVF Failure
NCT03701750Phase 4Unknown
- Sponsor
- Shenzhen Zhongshan Urology Hospital
- Start
- Nov 2018
- Primary completion
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of enoxaparin in infertility (2 arms), sponsored by Shenzhen Zhongshan Urology Hospital. Primary endpoint: Live birth rate at 42 weeks. Status: unknown.
02
Drugs
enoxaparin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03701750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03701750.